✨ Medicines Notices




NEW ZEALAND GAZETTE, No. 25 β€” 9 MARCH 2017

Tofacitinib
Velpatasvir
Vorapaxar

Schedule 3

Pharmacy-only Medicines

Bifonazole; for dermal use; except for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board

Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams and not more than 50 grams; in slow-release forms containing 665 milligrams or less and more than 500 milligrams; in powder form containing not more than 1 gram per sachet and more than 10 grams per pack

Medicines for General Sale

Please note that the following medicines are now available for general sale.

Albutrepenonacog alfa

Bifonazole; for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board

Deoxycholic acid; for oral use

Rurioctocog alfa pegol

Dated this 6th day of March 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health.

2017-go1101

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Alirocumab
Dosage Form:
75mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Product:
Eliriduc

Product:
Active Ingredient:
Alirocumab
Dosage Form:
150mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Product:
Golyra

Product:
Active Ingredient:
Alirocumab
Dosage Form:
75mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Product:
Golyra

Product:
Active Ingredient:
Alirocumab
Dosage Form:
150mg/mL
Solution for injection
New Zealand Sponsor:
Sanofi-Aventis New Zealand Limited
Manufacturers:
Sanofi Winthrop Industrie, Le Trait, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

68



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 25





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
6 March 2017
Medicines Classification, Prescription Medicines, Pharmacy-Only Medicines, General Sale Medicines, Medsafe, Ministry of Health
  • CHRIS JAMES, Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
New Medicines, Distribution, Alirocumab, Sanofi-Aventis